Media Resources

Date	Title
Sep 20, 2021	GBT Announces Participation at the Cantor Global Healthcare Conference
Sep 14, 2021	GBT Establishes The GBT Foundation to Improve the Health and Well-being of Underserved Patient Communities Around the World
Sep 09, 2021	GBT Announces New Employment Inducement Grants
Sep 08, 2021	GBT and Sickle Cell Disease Association of America to Host 10th Annual Sickle Cell Disease (SCD) Therapeutics Conference
Sep 07, 2021	U.S. FDA Accepts for Priority Review Supplemental New Drug Application for Oxbryta® (voxelotor) for the Treatment of Sickle Cell Disease in Children Ages 4 to 11

Media and Investor Contact

Steven Immergut
SVP, Head of Corporate Communications and Investor Relations
650-410-3258
simmergut@gbt.com